Loading…
Edgewise Therapeutics, Inc. is projected to rise to $39.31 by 2027, a +17% move from its current price of $33.54. EWTX is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $32.65 | $33.55 | $34.47 | +0.03% |
| May 30 | $32.30 | $33.56 | $34.87 | +0.05% |
| May 31 | $32.03 | $33.57 | $35.18 | +0.08% |
| Jun 1 | $31.81 | $33.58 | $35.44 | +0.10% |
| Jun 2 | $31.61 | $33.58 | $35.68 | +0.13% |
| Jun 3 | $31.44 | $33.59 | $35.89 | +0.16% |
| Jun 4 | $31.28 | $33.60 | $36.09 | +0.18% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $31.28 | $33.60 | $36.09 | +0.18% |
| Week 2 | $30.42 | $33.66 | $37.25 | +0.37% |
| Week 3 | $29.79 | $33.73 | $38.18 | +0.55% |
| Week 4 | $29.28 | $33.79 | $38.99 | +0.74% |
| Week 5 | $28.84 | $33.85 | $39.72 | +0.92% |
| Week 6 | $28.46 | $33.91 | $40.41 | +1.11% |
| Week 7 | $28.11 | $33.97 | $41.06 | +1.29% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Edgewise Therapeutics, Inc. is a biopharmaceutical company that discovers, develops, and commercializes therapies for the treatment of muscle disorders. Its lead product candidate, sevasemten, is an orally administered small molecule in Phase II clinical trials designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy.
The company also develops EDG-7500, a small molecule for hypertrophic cardiomyopathy and other severe cardiac disorders in Phase I, and EDG-15400, a novel small molecule for heart failure with preserved ejection fraction. The company was incorporated in 2017 and is headquartered in Boulder, Colorado, with a pipeline of precision medicine product candidates targeting key muscle proteins and modulators to address genetically defined muscle disorders.
Edgewise Therapeutics, Inc. (EWTX) is currently priced at $32.70 per share, with a market cap of $3.52B and a market-rank of 1606. The stock’s near-term outlook sits in a bullish technical stance, while the multi-year forecast envisions a substantial rise in average prices from 2026 through 2050.
The forecast provides a yearly ladder of min/avg/max values and ROI, illustrating a rising trajectory across the period.
A major floor 21.2% below — a decisive break under it would weaken the trend.
The nearest floor, 9.2% below — buyers have tended to step in here.
The nearest ceiling, 13.3% above — a clean break opens room to run.
A major ceiling 23.9% above — clearing it would confirm fresh momentum.
Key EWTX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of EWTX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $33.06 | Buy | $33.16 | Buy |
| MA 10 | $32.93 | Buy | $33.14 | Buy |
| MA 20 | $33.36 | Buy | $33.11 | Buy |
| MA 50 | $32.51 | Buy | $32.26 | Buy |
| MA 100 | $30.49 | Buy | $30.06 | Buy |
| MA 200 | $24.30 | Buy | $26.65 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 52.83 | Neutral |
| Stoch RSI (14) | 56.42 | Neutral |
| CCI (20) | 7.51 | Neutral |
| Williams %R (14) | -49.16 | Info |
| MACD (12,26,9) | -0.11 | Sell |
| ROC (12) | -5.04 | Sell |
| Bollinger %B (20,2) | 0.52 | Neutral |
| Stochastic %K (14) | 50.84 | Neutral |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | -0.02 | Sell |
| Ultimate (7,14,28) | 47.46 | Neutral |
| Momentum (10) | -0.47 | Sell |
| Aroon Osc (25) | 16.00 | Buy |
| Hull MA (9) | 33.38 | Buy |
| ADX (14) | 10.07 | Neutral |
| ATR (14) | 0.75 | Info |
The near-term picture shows bullish sentiment with a current price of $32.70. The 50-day simple moving average is $32.36 and the 200-day simple moving average is $24.09. Key intraday levels include support at $30.45 and resistance at $38.01, with a 30-day range of $27.14 to $39.40.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $22.94 | $33.54 | $45.09 | 0% | Neutral | |
| $31.20 | $39.31 | $52.44 | +17% | Neutral | |
| $33.93 | $43.90 | $60.68 | +31% | Bullish | |
| $41.72 | $55.21 | $78.48 | +65% | Bullish | |
| $49.71 | $67.12 | $97.70 | +100% | Bullish | |
| $55.08 | $75.72 | $112.53 | +126% | Bullish | |
| $62.17 | $86.94 | $131.63 | +159% | Bullish | |
| $62.82 | $89.26 | $137.47 | +166% | Bullish | |
| $66.13 | $95.41 | $149.23 | +184% | Bullish | |
| $73.14 | $107.05 | $169.90 | +219% | Bullish | |
| $112.39 | $175.73 | $296.41 | +424% | Bullish | |
| $226.72 | $397.15 | $732.24 | +10.8x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $22.94 | $33.54 | $39.31 | +0.00% |
| June 2026 | $28.30 | $33.23 | $39.94 | -0.93% |
| July 2026 | $29.01 | $34.35 | $41.84 | +3.38% |
| August 2026 | $29.78 | $35.49 | $43.67 | +3.31% |
| September 2026 | $29.33 | $35.14 | $43.60 | -0.98% |
| October 2026 | $29.09 | $35.02 | $43.79 | -0.33% |
| November 2026 | $29.64 | $35.85 | $45.12 | +2.35% |
| December 2026 | $29.32 | $35.60 | $45.09 | -0.68% |
Click any year to see its month-by-month EWTX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect EWTX to range from $22.94 to $45.09 through 2026. The $33.54 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The EWTX price prediction for 2027 points to an average of $39.31 (low $31.20, high $52.44) — a potential gain of +17% on today's $33.54. Price action looks broadly range-bound.
In 2028, EWTX is projected to trade between $33.93 and $60.68, averaging $43.90 — a potential gain of +31% from today's $33.54. That is up +12% on the projected 2027 average. Buyers look set to stay in control over this stretch.
Edgewise Therapeutics, Inc.'s 2029 outlook centres on $55.21, within a $41.72 to $78.48 range. That is up +26% on the projected 2028 average. That marks a +65% change versus current levels. Momentum favours further upside here.
By 2030, EWTX could reach as high as $97.70, with a base case around $67.12 and support toward $49.71 — roughly +100% from $33.54. Buyers look set to stay in control over this stretch.
Expect EWTX to range from $55.08 to $112.53 through 2031. The $75.72 average target implies a +126% move from current prices. That is up +13% on the projected 2030 average. Momentum favours further upside here.
The EWTX price prediction for 2032 points to an average of $86.94 (low $62.17, high $131.63) — a potential gain of +159% on today's $33.54. Buyers look set to stay in control over this stretch.
In 2033, EWTX is projected to trade between $62.82 and $137.47, averaging $89.26 — a potential gain of +166% from today's $33.54. That is up +3% on the projected 2032 average. Momentum favours further upside here.
Edgewise Therapeutics, Inc.'s 2034 outlook centres on $95.41, within a $66.13 to $149.23 range. That is up +7% on the projected 2033 average. That marks a +184% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, EWTX could reach as high as $169.90, with a base case around $107.05 and support toward $73.14 — roughly +219% from $33.54. Momentum favours further upside here.
Expect EWTX to range from $112.39 to $296.41 through 2040. The $175.73 average target implies a +424% move from current prices. That is up +64% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The EWTX price prediction for 2050 points to an average of $397.15 (low $226.72, high $732.24) — a potential gain of +10.8x on today's $33.54. Momentum favours further upside here.
Investing $1,000 in EWTX today (≈ 29.815146 EWTX) could be worth
$11,841.13
+$10,841.13 (+1084%) by 2050 · US Dollar
Based on the average projected EWTX price of $397.15 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in EWTXwould be worth at today's price.
$1,000 invested in EWTX on May 27, 2025 (≈ 69.808029 EWTX) would be worth
$2,341.36
+$1,341.36 (+134.1%) today · 2.34× · US Dollar
Based on a EWTX entry price of $14.32 vs. today's $33.54.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $32.82 | $1,021.94 | +2.2% |
| 1 month ago | $30.64 | $1,094.65 | +9.5% |
| 3 months ago | $29.66 | $1,130.82 | +13.1% |
| 6 months ago | $26.04 | $1,288.02 | +28.8% |
| 1 year ago | $14.32 | $2,341.36 | +134.1% |
| All time (5.0y) ago | $28.58 | $1,173.55 | +17.4% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our EWTX forecast.
Our base-case forecast reaches $67.00 around 2030.
Implied market cap at $67.00: $7.21B
The multi-year forecast projects a bullish trajectory from 2028 onward, with the average price rising from $43.52 in 2028 to $405.91 by 2050. Notable yearly milestones include 2028 avg $43.52 (ROI 33.1%), 2030 avg $67.16 (ROI 105.4%), 2040 avg $179.57 (ROI 449.2%), and 2050 avg $405.91 (ROI 1141.3%). The forecast also notes neutral sentiment in 2026 and 2027, followed by sustained bullish momentum through 2035 and into 2040 and 2050.
These figures are estimates and not guarantees; actual results can differ based on market conditions and other factors.
Tap a question to reveal the answer.
The forecast for 2030 shows min $49.34, avg $67.16, max $98.68 with an ROI of 105.4% and a bullish sentiment.
The long-term forecast turns bullish starting around 2028–2029 with rising average prices (e.g., 2028 avg $43.52, 2030 avg $67.16, 2050 avg $405.91) and positive ROIs (e.g., 2030 ROI 105.4%, 2050 ROI 1141.3%). Note that 2026–2027 are neutral, and forecasts are estimates, not guarantees.
In 2030 the max is $98.68, just under $100. However, later years project higher values, with 2040 max $307.23 and 2050 max $761.05.
Current price is $32.70 and market cap is $3.52B.
Near term sentiment is BULLISH. RSI(14) is 50, SMA50 is $32.36, SMA200 is $24.09. The stock shows support at $30.45 and resistance at $38.01, with a 30-day range of $27.14 to $39.40 and annualized volatility of 50%.
Edgewise Therapeutics, Inc. Community Discussion
0Share your Edgewise Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.